283 related articles for article (PubMed ID: 23906999)
1. Topiramate treatment for alcoholic outpatients recently receiving residential treatment programs: a 12-week, randomized, placebo-controlled trial.
Likhitsathian S; Uttawichai K; Booncharoen H; Wittayanookulluk A; Angkurawaranon C; Srisurapanont M
Drug Alcohol Depend; 2013 Dec; 133(2):440-6. PubMed ID: 23906999
[TBL] [Abstract][Full Text] [Related]
2. Oral topiramate reduces the consequences of drinking and improves the quality of life of alcohol-dependent individuals: a randomized controlled trial.
Johnson BA; Ait-Daoud N; Akhtar FZ; Ma JZ
Arch Gen Psychiatry; 2004 Sep; 61(9):905-12. PubMed ID: 15351769
[TBL] [Abstract][Full Text] [Related]
3. Effects of topiramate or naltrexone on tobacco use among male alcohol-dependent outpatients.
Baltieri DA; Daró FR; Ribeiro PL; Andrade AG
Drug Alcohol Depend; 2009 Nov; 105(1-2):33-41. PubMed ID: 19595518
[TBL] [Abstract][Full Text] [Related]
4. Topiramate for migraine prevention in children: a randomized, double-blind, placebo-controlled trial.
Winner P; Pearlman EM; Linder SL; Jordan DM; Fisher AC; Hulihan J;
Headache; 2005; 45(10):1304-12. PubMed ID: 16324162
[TBL] [Abstract][Full Text] [Related]
5. Topiramate reduces the harm of excessive drinking: implications for public health and primary care.
Ma JZ; Ait-Daoud N; Johnson BA
Addiction; 2006 Nov; 101(11):1561-8. PubMed ID: 17034435
[TBL] [Abstract][Full Text] [Related]
6. Comparing topiramate with naltrexone in the treatment of alcohol dependence.
Baltieri DA; Daró FR; Ribeiro PL; de Andrade AG
Addiction; 2008 Dec; 103(12):2035-44. PubMed ID: 18855810
[TBL] [Abstract][Full Text] [Related]
7. Oral topiramate for treatment of alcohol dependence: a randomised controlled trial.
Johnson BA; Ait-Daoud N; Bowden CL; DiClemente CC; Roache JD; Lawson K; Javors MA; Ma JZ
Lancet; 2003 May; 361(9370):1677-85. PubMed ID: 12767733
[TBL] [Abstract][Full Text] [Related]
8. Topiramate for treating alcohol dependence: a randomized controlled trial.
Johnson BA; Rosenthal N; Capece JA; Wiegand F; Mao L; Beyers K; McKay A; Ait-Daoud N; Anton RF; Ciraulo DA; Kranzler HR; Mann K; O'Malley SS; Swift RM; ;
JAMA; 2007 Oct; 298(14):1641-51. PubMed ID: 17925516
[TBL] [Abstract][Full Text] [Related]
9. Cessation versus continuation of 6-month migraine preventive therapy with topiramate (PROMPT): a randomised, double-blind, placebo-controlled trial.
Diener HC; Agosti R; Allais G; Bergmans P; Bussone G; Davies B; Ertas M; Lanteri-Minet M; Reuter U; Sánchez Del Río M; Schoenen J; Schwalen S; van Oene J;
Lancet Neurol; 2007 Dec; 6(12):1054-62. PubMed ID: 17988947
[TBL] [Abstract][Full Text] [Related]
10. Cognitive changes in topiramate-treated patients with alcoholism: a 12-week prospective study in patients recently detoxified.
Likhitsathian S; Saengcharnchai P; Uttawichai K; Yingwiwattanapong J; Wittayanookulluk A; Srisurapanont M
Psychiatry Clin Neurosci; 2012 Apr; 66(3):235-41. PubMed ID: 22443246
[TBL] [Abstract][Full Text] [Related]
11. Topiramate reduces headache days in chronic migraine: a randomized, double-blind, placebo-controlled study.
Diener HC; Bussone G; Van Oene JC; Lahaye M; Schwalen S; Goadsby PJ;
Cephalalgia; 2007 Jul; 27(7):814-23. PubMed ID: 17441971
[TBL] [Abstract][Full Text] [Related]
12. Efficacy of valproate maintenance in patients with bipolar disorder and alcoholism: a double-blind placebo-controlled study.
Salloum IM; Cornelius JR; Daley DC; Kirisci L; Himmelhoch JM; Thase ME
Arch Gen Psychiatry; 2005 Jan; 62(1):37-45. PubMed ID: 15630071
[TBL] [Abstract][Full Text] [Related]
13. Efficacy and safety of topiramate for the treatment of chronic migraine: a randomized, double-blind, placebo-controlled trial.
Silberstein SD; Lipton RB; Dodick DW; Freitag FG; Ramadan N; Mathew N; Brandes JL; Bigal M; Saper J; Ascher S; Jordan DM; Greenberg SJ; Hulihan J;
Headache; 2007 Feb; 47(2):170-80. PubMed ID: 17300356
[TBL] [Abstract][Full Text] [Related]
14. A placebo-controlled, random-assignment, parallel-group pilot study of adjunctive topiramate for patients with schizoaffective disorder, bipolar type.
Roy Chengappa K; Kupfer DJ; Parepally H; John V; Basu R; Buttenfield J; Schlicht P; Houck P; Brar JS; Gershon S
Bipolar Disord; 2007 Sep; 9(6):609-17. PubMed ID: 17845276
[TBL] [Abstract][Full Text] [Related]
15. Topiramate versus amitriptyline in migraine prevention: a 26-week, multicenter, randomized, double-blind, double-dummy, parallel-group noninferiority trial in adult migraineurs.
Dodick DW; Freitag F; Banks J; Saper J; Xiang J; Rupnow M; Biondi D; Greenberg SJ; Hulihan J;
Clin Ther; 2009 Mar; 31(3):542-59. PubMed ID: 19393844
[TBL] [Abstract][Full Text] [Related]
16. The impact of topiramate on health-related quality of life indicators in chronic migraine.
Dodick DW; Silberstein S; Saper J; Freitag FG; Cady RK; Rapoport AM; Mathew NT; Hulihan J; Crivera C; Rupnow MF; Mao L; Finlayson G; Greenberg SJ
Headache; 2007; 47(10):1398-408. PubMed ID: 18052949
[TBL] [Abstract][Full Text] [Related]
17. A Randomized Trial Evaluating Whether Topiramate Aids Smoking Cessation and Prevents Alcohol Relapse in Recovering Alcohol-Dependent Men.
Anthenelli RM; Heffner JL; Wong E; Tibbs J; Russell K; Isgro M; Dinh E; Wehrle C; Worley MJ; Doran N
Alcohol Clin Exp Res; 2017 Jan; 41(1):197-206. PubMed ID: 28029173
[TBL] [Abstract][Full Text] [Related]
18. Improvement of physical health and quality of life of alcohol-dependent individuals with topiramate treatment: US multisite randomized controlled trial.
Johnson BA; Rosenthal N; Capece JA; Wiegand F; Mao L; Beyers K; McKay A; Ait-Daoud N; Addolorato G; Anton RF; Ciraulo DA; Kranzler HR; Mann K; O'Malley SS; Swift RM; ;
Arch Intern Med; 2008 Jun; 168(11):1188-99. PubMed ID: 18541827
[TBL] [Abstract][Full Text] [Related]
19. A randomized double-blind placebo-controlled study of the long-term efficacy and safety of topiramate in the treatment of obese subjects.
Wilding J; Van Gaal L; Rissanen A; Vercruysse F; Fitchet M;
Int J Obes Relat Metab Disord; 2004 Nov; 28(11):1399-410. PubMed ID: 15486569
[TBL] [Abstract][Full Text] [Related]
20. Topiramate for migraine prevention in adolescents: a pooled analysis of efficacy and safety.
Winner P; Gendolla A; Stayer C; Wang S; Yuen E; Battisti WP; Nye JS
Headache; 2006; 46(10):1503-10. PubMed ID: 17115983
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
